Consensus ICON Public Limited Company

Equities

ICLR

IE0005711209

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 23/01/2026 GMT			5-day change	1st Jan Change
186.70 ^USD	-0.02%		+2.24%	+2.46%

01-08	Peace Was Cheaper
01-08	Truist Downgrades ICON PLC to Hold From Buy, Trims Price Target to $222 From $231	MT

Evolution of the Average Target: ICON Public Limited Company

Evolution of the Target Price: ICON Public Limited Company

Changes in Analyst Recommendations: ICON Public Limited Company

15a48b55528c1a14d587204f6.GH_qoq1MBnqdKzqEkOzz-5HRB5EcDxUR7XrOAEa28TE.KCen45kINx6sXkm3_ojGrvyCYcF3RyNppSX6UgvlhAlUJ5z05TY3DO1xew~c9ff6e9ad9b186d06a1cf3d595ec907a

Analysts' recommendations: ICON Public Limited Company

01-08	Truist Downgrades ICON PLC to Hold From Buy, Trims Price Target to $222 From $231	MT
01-08	Analyst recommendations: Alphabet, Chubb, Ford, Stellantis, The Gap…
12-15	BofA Securities Downgrades ICON to Neutral From Buy	MT
11-13	BMO Capital Initiates Coverage on ICON With Market Perform Rating, $175 Price Target	MT
24/10/25	Truist Trims Price Target on ICON PLC to $231 From $234, Keeps Buy Rating	MT
24/10/25	Deutsche Bank Trims Price Target on ICON PLC to $205 From $210, Keeps Buy Rating	MT
20/10/25	BofA Adjusts Price Target on ICON to $215 From $220	MT
12/09/25	Analyst recommendations: Applovin, Casey’s General Stores, Ralph Lauren, Medpace Holdings, Air Products & Chemicals...
09/09/25	ICON Shares Decline After Jefferies Downgrade	MT
09/09/25	Jefferies Downgrades ICON to Hold From Buy, $175 Price Target	MT
03/09/25	ICON Shares Rise After Rothschild & Co Redburn Upgrade	MT
03/09/25	Analyst recommendations: Accenture, Chipotle, Kraft, Lucid Group, Thor Industries…
03/09/25	Rothschild & Co Redburn Upgrades ICON to Buy From Neutral, Adjusts PT to $236 From $184	MT
21/08/25	The Bubble Flickers
21/08/25	Citigroup Downgrades ICON to Neutral From Buy, $225 Price Target	MT
21/08/25	Analyst recommendations: Coreweave, Coty, Marvell, Snap, AMD…
29/07/25	Deutsche Bank Adjusts ICON Price Target to $210 From $200, Maintains Buy Rating	MT
25/07/25	UBS Adjusts Price Target on ICON to $240 From $170, Maintains Buy Rating	MT
25/07/25	Truist Raises Price Target on ICON to $234 From $187, Keeps Buy Rating	MT
24/07/25	Sector Update: Health Care Stocks Softer Late Afternoon	MT
24/07/25	Analyst recommendations: Alphabet, IBM, Thermo Fisher Scientific, Lockheed Martin, ServiceNow...
24/07/25	Baird Upgrades ICON to Outperform From Neutral, Price Target is $150	MT
09/07/25	Truist Trims Price Target on ICON to $187 From $190, Keeps Buy Rating	MT
23/05/25	Analyst recommendations: Crowdstrike, AMD, Boeing, Intuit, Okta…
05/05/25	Truist Securities Adjusts Price Target on ICON to $190 From $208, Keeps Buy Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ICON PUBLIC LIMITED COMPANY					+10.51%
	LONZA GROUP AG					+22.07%
	IQVIA HOLDINGS INC.					+9.24%
	BEONE MEDICINES AG					+19.3%
	CELLTRION, INC.					+13.34%
	REVOLUTION MEDICINES, INC.					-8.61%
	MEDPACE HOLDINGS, INC.					-9.98%
	Average					+7.98%
	Weighted average by Cap.					+11.20%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

186.70USD

Average target price

206.38USD

Spread / Average Target

+10.54%

High Price Target

243.00USD

Spread / Highest target

+30.16%

Low Price Target

175.00USD

Spread / Lowest Target

-6.27%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Truist Securities
BofA Securities
BMO Capital
Deutsche Bank Securities
Jefferies & Co.
Rothschild & Co Redburn
Citigroup
UBS
Baird
JPMorgan Chase
TD Cowen
Barclays
Goldman Sachs
RBC Capital Markets
Nephron Research
Leerink Partners
Evercore ISI
Mizuho Securities
Wells Fargo Securities
Morningstar
Guggenheim
Credit Suisse